gadolinium DOTA meglumine manufacturers
|
| | gadolinium DOTA meglumine Basic information |
| Product Name: | gadolinium DOTA meglumine | | Synonyms: | gadolinium DOTA meglumine;Gd-DOTA meglumine;Magnescope;P 449;D-Glucitol, 1-deoxy-1-(methylamino)-, [1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetato(4-)-kN1,kN4,kN7,kN10,kO1,kO4,kO7,kO10]gadolinate(1-) (1:1);gadolinium 2,2',2''-[10-(carboxymethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl]triacetate - 1-deoxy-1-(methylamino)-D-glucitol (1:1);Gadolinium 2,2',2''-[10-(carboxymethyl)-1,4,7,10-tetraazacyclodod Ecane-1,4,7-triyl]triacetate - 1-deoxy-1-(methylamino)-d-glucitol (1:1:1);gadolinium DOTA meglumine USP/EP/BP | | CAS: | 92943-93-6 | | MF: | C23H42GdN5O13 | | MW: | 753.86 | | EINECS: | | | Product Categories: | | | Mol File: | 92943-93-6.mol |  |
| | gadolinium DOTA meglumine Chemical Properties |
| | gadolinium DOTA meglumine Usage And Synthesis |
| Uses | Gadolinium Dota Meglumine is used in the preparation of Macrocyclic Gadolinium-?Based Contrast Agents. | | Definition | ChEBI: An organoammonium salt obtained by reaction of gadoteric acid with one equivalent of 1-deoxy-1-(methylamino)-D-glucitol (meglumine). It is used in magnetic resonance imaging (MRI) in brain (intracranial), spine and associated tissues of pa
ients ages 2 years and older, to detect and visualise areas with disruption of the blood brain barrier and/or abnormal vascularity of the central nervous system. |
| | gadolinium DOTA meglumine Preparation Products And Raw materials |
|